Invention Grant
US08173809B2 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
有权
半胱氨酸和胱氨酸前药用于治疗精神分裂症并减少药物渴求
- Patent Title: Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
- Patent Title (中): 半胱氨酸和胱氨酸前药用于治疗精神分裂症并减少药物渴求
-
Application No.: US12367867Application Date: 2009-02-09
-
Publication No.: US08173809B2Publication Date: 2012-05-08
- Inventor: James M. Cook , David A. Baker , Wenyuan Yin , Edward Merle Johnson, II
- Applicant: James M. Cook , David A. Baker , Wenyuan Yin , Edward Merle Johnson, II
- Applicant Address: US WI Milwaukee US WI Milwaukee
- Assignee: Marquette University,UWM Research Foundation, Inc.
- Current Assignee: Marquette University,UWM Research Foundation, Inc.
- Current Assignee Address: US WI Milwaukee US WI Milwaukee
- Agency: Quarles & Brady LLP
- Main IPC: C07D295/00
- IPC: C07D295/00
Abstract:
The present invention provides cysteine and cystine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction. Exemplary prodrugs include the cysteine compound having the formula as well as cystine dimers thereof.
Public/Granted literature
- US20090281109A1 CYSTEINE AND CYSTINE PRODRUGS TO TREAT SCHIZOPHRENIA AND REDUCE DRUG CRAVINGS Public/Granted day:2009-11-12
Information query
